[go: up one dir, main page]

NO20082265L - Dispergerbare tabletter som innbefatter deferasirox - Google Patents

Dispergerbare tabletter som innbefatter deferasirox

Info

Publication number
NO20082265L
NO20082265L NO20082265A NO20082265A NO20082265L NO 20082265 L NO20082265 L NO 20082265L NO 20082265 A NO20082265 A NO 20082265A NO 20082265 A NO20082265 A NO 20082265A NO 20082265 L NO20082265 L NO 20082265L
Authority
NO
Norway
Prior art keywords
deferasirox
dispersible tablets
tablets including
dispersible
tablet
Prior art date
Application number
NO20082265A
Other languages
English (en)
Inventor
Florian Battung
Jean-Pierre Cassiere
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20082265L publication Critical patent/NO20082265L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en dispergerbar tablett som omfatter (a) forbindelse I med formelen (I) eller et farmasøytisk akseptabelt salt derav som er tilstede i en mengde på fra 42 til 65 vekt-% basert på den totale vekten av tabletten, og (b) minst en farmasøytisk akseptabel eksipient som er egnet for fremstillingen av dispergerbare tabletter, og fremgangsmåte for å fremstille nevnte dispergerbare tablett.
NO20082265A 2005-10-19 2008-05-16 Dispergerbare tabletter som innbefatter deferasirox NO20082265L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0553182 2005-10-19
PCT/EP2006/010020 WO2007045445A1 (en) 2005-10-19 2006-10-17 Dispersible tablets comprising deferasirox

Publications (1)

Publication Number Publication Date
NO20082265L true NO20082265L (no) 2008-05-16

Family

ID=36616771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082265A NO20082265L (no) 2005-10-19 2008-05-16 Dispergerbare tabletter som innbefatter deferasirox

Country Status (17)

Country Link
US (1) US20080311194A1 (no)
EP (1) EP1940360A1 (no)
JP (1) JP2009512652A (no)
KR (1) KR20080056225A (no)
CN (1) CN101291655A (no)
AU (1) AU2006303514B2 (no)
BR (1) BRPI0617715A2 (no)
CA (1) CA2625112A1 (no)
EC (1) ECSP088379A (no)
IL (1) IL190397A0 (no)
MA (1) MA29841B1 (no)
NO (1) NO20082265L (no)
NZ (1) NZ567155A (no)
RU (1) RU2008119410A (no)
TN (1) TNSN08173A1 (no)
WO (1) WO2007045445A1 (no)
ZA (1) ZA200802670B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062572A1 (en) 2007-11-19 2009-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions
WO2010035282A1 (en) * 2008-09-24 2010-04-01 Matrix Laboratories Limited Pharmaceutical compositions comprising deferasirox
EA201390079A1 (ru) 2010-07-08 2013-09-30 Рациофарм Гмбх Пероральная лекарственная форма деферазирокса
CA2812505A1 (en) * 2010-10-01 2012-04-05 Cipla Limited Pharmaceutical composition
WO2014072673A1 (en) 2012-11-12 2014-05-15 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
KR20170045391A (ko) * 2013-03-08 2017-04-26 노파르티스 아게 데페라시록스의 경구 제제
MX2015015553A (es) * 2013-05-10 2016-06-17 Cipla Ltd Composicion farmceutica de dosis baja.
ES2734675T3 (es) 2014-05-20 2019-12-11 Sanovel Ilac Sanayi Ve Ticaret As Formulación de comprimido dispersable en agua que contiene deferasirox
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
EP3095443A1 (en) * 2015-05-21 2016-11-23 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Pharmaceutical composition comprising deferasirox
MA43271A (fr) * 2015-06-17 2018-09-26 Dispersol Technologies Llc Formulations améliorées de déférasirox et leurs procédés de fabrication
WO2018007956A1 (en) * 2016-07-05 2018-01-11 Jubilant Generics Limited Immediate release pharmaceutical composition of iron chelating agents
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
WO2019108157A1 (en) * 2017-11-28 2019-06-06 Biofarma Ilac Sanayi Ve Ticaret A.S. A scored tablet formulation in a dispersible form comprising deferasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
WO2022240279A1 (es) * 2021-05-10 2022-11-17 Garcia Perez Miguel Angel Tableta dispersable con deferasirox en forma de dispersión sólida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
KR20080056225A (ko) 2008-06-20
ECSP088379A (es) 2008-05-30
AU2006303514B2 (en) 2010-06-24
IL190397A0 (en) 2008-11-03
AU2006303514A1 (en) 2007-04-26
TNSN08173A1 (en) 2009-10-30
WO2007045445A1 (en) 2007-04-26
CN101291655A (zh) 2008-10-22
CA2625112A1 (en) 2007-04-26
JP2009512652A (ja) 2009-03-26
US20080311194A1 (en) 2008-12-18
BRPI0617715A2 (pt) 2011-08-02
RU2008119410A (ru) 2009-11-27
ZA200802670B (en) 2009-10-28
MA29841B1 (fr) 2008-10-03
EP1940360A1 (en) 2008-07-09
NZ567155A (en) 2010-06-25

Similar Documents

Publication Publication Date Title
NO20082265L (no) Dispergerbare tabletter som innbefatter deferasirox
NO20045072L (no) Tablett med hoyt medikamentinnhold
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
NO20063583L (no) Krystallinsk polymorf av et bisulfatsalt av en trombinreseptorantagonist
NO20090328L (no) Nye forbindelser 385
NO20074703L (no) Antibakterielle piperidinderivater
NO20064065L (no) Diaminopyrimidiner som P2X3 og P2X2/3 antagonister
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
SG155961A1 (en) Pyrazoles as 11-beta-hsd-1
NO20081889L (no) Fast vaksine formulering
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
NO20060947L (no) β d-krystalinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20084382L (no) Sykloalkylaminosyrederivater og farmasoytiske sammensetninger derav
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
NO20064588L (no) Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den
WO2007135527A3 (en) Benzimidazolyl compounds
NO20070445L (no) Pyrimidinderivater.
NZ600231A (en) Pharmaceutical compositions comprising sigma receptor ligands
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
TW200643013A (en) Pyrazoles
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2006025070A3 (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application